SYNaPsE - SYNergising Patient Engagement
made with patients
SYNaPsE - SYNergising Patient Engagement
  • People
  • Organizations
  • Initiatives
  • Events
  • Resources
  • Patient Pledge
    • Take the Pledge
    • The Pledge Record
  • Reports
  • Register
  • Login
Pledge icon

Ify Sargeant

Scientific editor

 The Synergist PFMD IsMedica

  • About
  • 3 Organizations
  • 3 Initiatives
  • 5 Resources
  • 3 Commitments

Organizations

The Synergist Scientific editor

The Synergist runs programmes aimed at solving challenges which others ignore or have been unable to...

PFMD

The Patient Focused Medicines Development (PFMD) group, established in 2015, is an independent multi...

IsMedica

IsMedica is a freelance medical writing service that is personal and professional. I understand the...

About

I am a medical writer and health communications consultant with over 18 years of experience. I gained a degree in Biochemistry and Molecular Biology (Manchester), post-graduate diploma in Journalism (London) and doctorate in Molecular Genetics (Oxford) before focusing on Public Understanding of Science within public affairs (Southampton). A stint in Press Relations (PR) at the Wellcome Trust (London) sealed my commitment to communicating about health and disease to a variety of audiences. Since 2000 I have been working as a medical writer mainly within oncology, rheumatoid arthritis and kidney disease. Writing about these 'chronic' conditions, highlighted how people affected must deal with the constant challenges they face and how they need to be involved from the get go in solutions to these challenges. Working with PFMD is a unique opportunity to make a difference by helping to ensure patients' needs and priorities are at the heart of medicines and health interventions that aim to make their lives better.

Contact Information

Social media Linkedin

Initiatives
3 of 3 Initiatives

  PFMD - Patient Focused Medicines Development

The Synergist, CANCER101, F. Hoffmann La Roche, Merck Sharp & Dohme,
Geographic focus
Global
Asset 5

  SYNaPsE Patient Engagement Global Landscape, Expert Network and Repository

The Synergist, CANCER101, F. Hoffmann La Roche, Merck Sharp & Dohme,
Geographic focus
Global
Asset 4

  Co-creation of the Patient Engagement "Meta-Framework"

The Synergist, CANCER101, F. Hoffmann La Roche, Merck Sharp & Dohme,
Geographic focus
Global
Time line
Completed over one year ago
3 of 5 Resources | See All

Resources

Understanding stakeholders expectations for patient engagement - Qualitative Survey

Added on
Mar-28-2018

Culture and Process Change as a Priority for Patient Engagement in Medicines Development - Article

Added on
Jan-12-2018

Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action - Article

Added on
Jan-12-2018
3 of 3 Commitments

Commitments

Ify Sargeant

Scientific editor

As Chair of the Patient and Public Involvement group at my local health trust, I will ask at least 1 patient representative 1 question at each meeting

Work in progress
Ify Sargeant

Scientific editor

For every publication planned, I will work with at least 1 patient or patient organisation representative from outline to completion

Work in progress
Ify Sargeant

Scientific editor

I will ask patients/patient organisations to contribute their views and perspectives through editorial blogs and commentaries at least every 3 months

Work in progress

Do you need help?

  • Contact us
  • Help Center

Useful links

  • About us
  • Features
  • Search tool
  • Terms and Conditions
  • Privacy Policy
  • Geographical
  • Medical scope
  • Timeline
  • Patient matrix
  • Medicine lifecycle

Join our newsletter

Get the latest information on Patient Focused Medicines Development and stay connected with our activities.

3.6.0@prod
© Copyright SYNAPSE 2019. All Rights Reserved Powered by The Synergist.
In order to make your visit to our website as enjoyable as possible, we use cookies. By continuing you are accepting cookies. See our Privacy Policy for more information.   Accept